With $30 Million Gift, UAB Says Cancer Research is the Future of Birmingham
Eva Carter is in her 70s and for most of her life, she says she never had any health problems. That changed five years ago.
“I was bulldozed with, ‘You have the most aggressive type of breast cancer,’” Carter says.
She received a diagnosis of triple negative breast cancer. Her doctors at UAB recommended a clinical trial. She would test out a new drug therapy not yet approved by the FDA. Carter agreed to give it a try.
“I was fighting for my life and anything that I could do to enhance my chances of living longer, I was going to do it,” she says. “If it didn’t work, it didn’t work.”
Clinical trials are experiments, research studies to test the effectiveness of a new drug. The cancer center’s director, Dr. Michael Birrer, says that should not deter patients. He says today, more than ever, these studies are carefully done and represent the future of oncology research. For that reason, the center wants to do more of them, with plans to eventually triple its number of clinical trials. Birrer says they are especially interested in increasing the amount of early phase trials, when drugs are first tested on humans.
“It’s no longer, ‘Hey here’s a phase 1 and your chance of responding is very low,’” Birrer says. “We now have success rates in these trials that’s high, and so it’s much more relevant to patients.”
There is also an economic incentive. Birrer says the recent $30 million gift from O’Neal Industries will help fund physician-led research, hire clinical staff and increase patient participation. This lays the groundwork to attract small pharmaceutical, or biotech companies. Birrer says these groups are changing the face of research. They are nimble and hungry to develop new therapies. With enough investment, he says Birmingham could develop a biotech park in the future.
“Companies will come and say, ‘We have a new agent, looks good. Can you open this trial up and get the job done?’” Birrer says. “If we can do that fast enough and we do that often enough, I think they’ll open up an office down here or they might even bring their headquarters down here.”
For patients, that means access to the newest therapies, and they typically do not have to pay for treatment. But participating in a clinical trial is not easy. They often require daily or weekly visits to the cancer center and following a diet or exercise plan. Additionally, there are the side effects. For Eva Carter, it was worth it.
“My oncologist called me at 8’oclock one night, and I said, ‘Oh lord, does this mean I’m dead?’” Carter says, “and he called and said, ‘I just saw your MRI and we can’t even measure the tumor now. We can’t even measure it.’”
Carter says she understands why some people hesitate to participate in trials. Specifically within the African-American community, she says there is a legacy of distrust, marked by the Tuskegee study, when African-American men were unknowingly left untreated for syphilis for decades. Carter says that is why it is especially important patients have doctors they can trust, who explain the clinical trial and any risks associated with it. She also says patients should do their own research.
“I am so happy that the lord gave me the wisdom and the courage and the internet to look up the information on a clinical trial,” Carter says.
This year, more than 500 people have participated in a clinical trial at the O’Neal Comprehensive Cancer Center at UAB. Next year, the goal is to enroll about 700. The growth is expected to drive economic development, but more importantly, it will offer more patients, more options to fight cancer.
You can trust the jobs report, Labor Department workers urge public
A strongly-worded statement from Bureau of Labor Statistics workers comes a month after President Trump attacked the integrity of the jobs numbers they release monthly.
Headed to the FBI, Missouri’s Andrew Bailey opposed abortion, backed Trump
Andrew Bailey rose quickly to be state attorney general of Missouri where he built a record for fighting abortion and defending Donald Trump. Now he's a co-deputy director of the FBI.
How Chicago, Baltimore and New Orleans are reacting to Trump’s National Guard threats
Even after a federal court ruled his use of the National Guard in LA was illegal, the president has weighed sending troops to Chicago, Baltimore and New Orleans. Here's where things stand in those cities.
Watching a neighbor’s cat turns lethal in ‘Caught Stealing’
Darren Aronofsky's film is a funny, bloody valentine to 1990s New York City. Though awfully engrossing, Caught Stealing's mix of rambunctious slapstick and bone-crunching violence doesn't always gel.
Hundreds of South Koreans are among 475 detained in a Georgia immigration raid
"The business activities of our investors and the rights of our nationals must not be unjustly infringed," a foreign ministry spokesman said after about 300 South Koreans were detained.
Four Democratic senators urge Smithsonian to resist White House attempts to ‘bully the institution’
Sen. Alex Padilla of California and three other Democrats are reminding the Smithsonian's secretary that the institution "is the responsibility of Congress."
